<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Cayman Journal - Inovio Pharmaceuticals Inc (INO)</title>
    <description>Latest news, press releases, and SEC filings for Inovio Pharmaceuticals Inc (INO)</description>
    <link>https://caymanjournal.com/stock/INO</link>
    <language>en-us</language>
    
    <copyright>Copyright 2026, Cayman Journal</copyright>
    <managingEditor>editorial@caymanjournal.com (Editorial Team)</managingEditor>
    <webMaster>webmaster@caymanjournal.com (Web Master)</webMaster>
    <lastBuildDate>Mon, 27 Apr 2026 22:45:00 GMT</lastBuildDate>
    <ttl>60</ttl>
    <atom:link href="https://caymanjournal.com/stock/INO/feed.xml" rel="self" type="application/rss+xml" />
    <image>
      <url>https://caymanjournal.com/logo.png</url>
      <title>Cayman Journal</title>
      <link>https://caymanjournal.com</link>
      <width>144</width>
      <height>144</height>
    </image>

    <item>
      <title>DEF 14A — INOVIO PHARMACEUTICALS, INC.</title>
      <description># 🧾 What This Document Is
This is a **DEF 14A, or &quot;Proxy Statement.&quot;** It’s a formal document a company sends to its shareholders ahead of an annual meeting. Its purpose is to give shareholders the information they need to vote on important company matters. Think of it as an invitation to the compa</description>
      <link>https://caymanjournal.com/stock/INO/sec-filing/0001055726-26-000011</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/INO/sec-filing/0001055726-26-000011</guid>
      <pubDate>Tue, 07 Apr 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item>
  </channel>
</rss>